Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily.

[1]  F. Luft,et al.  Inducible NOS inhibition, eicosapentaenoic acid supplementation, and angiotensin II-induced renal damage. , 2005, Kidney international.

[2]  R. Agarwal.  Hypertension and survival in chronic hemodialysis patients--past lessons and future opportunities. , 2005, Kidney international.

[3]  I. Fleming.  Cytochrome P450 epoxygenases as EDHF synthase(s). , 2004, Pharmacological research.

[4]  Magnus Ingelman-Sundberg,et al.  Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. , 2004, The American journal of clinical nutrition.

[5]  Spencer S. Ericksen,et al.  Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acid. , 2004, Biochemical pharmacology.

[6]  M. Wellner,et al.  A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury. , 2004, The American journal of pathology.

[7]  Lawrence J Appel,et al.  Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[8]  T. Lu,et al.  Stereospecific activation of cardiac ATP-sensitive K(+) channels by epoxyeicosatrienoic acids: a structural determinant study. , 2002, Molecular pharmacology.

[9]  Hon-chi Lee,et al.  Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels. , 2002, The Journal of pharmacology and experimental therapeutics.

[10]  D. Jump.  The Biochemistry of n-3 Polyunsaturated Fatty Acids* 210 , 2002, The Journal of Biological Chemistry.

[11]  M. Gollasch,et al.  Cytochrome P450-Dependent Eicosapentaenoic Acid Metabolites Are Novel BK Channel Activators , 2002, Hypertension.

[12]  R. Roman,et al.  P-450 metabolites of arachidonic acid in the control of cardiovascular function. , 2002, Physiological reviews.

[13]  R. Head,et al.  Longchain n-3 polyunsaturated fatty acids and blood vessel function. , 2001, Cardiovascular research.

[14]  I. Fleming,et al.  Sphingolipid Mediators in Cardiovascular Cell Biology and Pathology , 2022 .

[15]  D. Zeldin.  Epoxygenase Pathways of Arachidonic Acid Metabolism* , 2001, The Journal of Biological Chemistry.

[16]  T. Lu,et al.  EET homologs potently dilate coronary microvessels and activate BK(Ca) channels. , 2001, American journal of physiology. Heart and circulatory physiology.

[17]  I. Roots,et al.  Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants. , 2001, Carcinogenesis.

[18]  J. Falck,et al.  Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase. , 2000, Journal of lipid research.

[19]  W. Connor,et al.  Importance of n-3 fatty acids in health and disease. , 2000, The American journal of clinical nutrition.

[20]  R. Busse,et al.  Cytochrome P450 2C is an EDHF synthase in coronary arteries , 1999, Nature.

[21]  V. Holla,et al.  The kidney cytochrome P-450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading. , 1999, The Journal of clinical investigation.

[22]  A. Simopoulos,et al.  Essential fatty acids in health and chronic disease. , 1999, The American journal of clinical nutrition.

[23]  J. Mcgiff,et al.  20-HETE and the kidney: resolution of old problems and new beginnings. , 1999, The American journal of physiology.

[24]  J. Falck,et al.  The Highly Stereoselective Oxidation of Polyunsaturated Fatty Acids by Cytochrome P450BM-3* , 1996, The Journal of Biological Chemistry.

[25]  E. Oliw,et al.  Dexamethasone induces bisallylic hydroxylation of polyunsaturated fatty acids by rat liver microsomes. , 1996, Archives of biochemistry and biophysics.

[26]  P. Pratt,et al.  Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. , 1996, Circulation research.

[27]  R. DuBois,et al.  Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform. , 1995, Archives of biochemistry and biophysics.

[28]  A. Dart,et al.  HOW DO FISH OILS AFFECT VASCULAR FUNCTION? , 1995, Clinical and experimental pharmacology & physiology.

[29]  D. Koop,et al.  Regio- and stereoselective epoxidation of arachidonic acid by human cytochromes P450 2C8 and 2C9. , 1994, The Journal of pharmacology and experimental therapeutics.

[30]  S. Imaoka,et al.  Identification of CYP2C23 expressed in rat kidney as an arachidonic acid epoxygenase. , 1993, The Journal of pharmacology and experimental therapeutics.

[31]  E. Oliw,et al.  Biosynthesis of prostaglandins from 17(18)epoxy-eicosatetraenoic acid, a cytochrome P-450 metabolite of eicosapentaenoic acid. , 1992, Biochimica et biophysica acta.

[32]  E. Oliw,et al.  Metabolism of polyunsaturated (n-3) fatty acids by monkey seminal vesicles: isolation and biosynthesis of omega-3 epoxides. , 1991, Biochimica et biophysica acta.

[33]  H. Knapp,et al.  Urinary excretion of diols derived from eicosapentaenoic acid during n-3 fatty acid ingestion by man. , 1991, Prostaglandins.

[34]  J. Falck,et al.  Synthesis of epoxyeicosatrienoic acids and heteroatom analogs. , 1990, Methods in enzymology.

[35]  O. Carretero,et al.  Oxidation of 5,8,11,14,17-eicosapentaenoic acid by hepatic and renal microsomes. , 1988, Biochimica et biophysica acta.

[36]  Y. Yasukochi,et al.  Some properties of a detergent-solubilized NADPH-cytochrome c(cytochrome P-450) reductase purified by biospecific affinity chromatography. , 1976, The Journal of biological chemistry.

[37]  T. Omura,et al.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. , 1964, The Journal of biological chemistry.